Recurrence of thymoma with pleural invasion in a patient with myasthenia gravis and pure red blood cell aplasia: a case report
Recurrencia de timoma con invasión pleural en un paciente con miastenia gravis y aplasia pura de globulos rojos: reporte de caso
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
Thymomas are thymic tumors that arise from epithelial cells, they have different morphological characteristics. It is known for its association with autoimmune diseases such as myasthenia gravis, pure red cell aplasia, systemic lupus erythematosus, or hypogammaglobulinemia pemphigus foliaceus.
The association of thymoma-myasthenia gravis-pure red cell aplasia is a rare one, there will be a case report with the corresponding discussion and review of the literature.
Article visits 79 | PDF visits 109
Downloads
- Morgenthaler TI, Brown LR, Colby TV, Harper CM, Coles dT. Thymoma. Mayo Clin Proc 1993; 68: 1110- 1123.
- Onodera H. Tohoku. The role of the thymus in the pathogenesis of myasthenia gravis. J Exp Med 2005; 207: 87- 98.
- Riedel RF, Burfeind WR Jr. Thymoma: Benign appearance, malignant potential. The Oncologist 2006; 11: 887- 894.
- Ammus SS. Yunis AA. Acquired pure red cell aplasia. Am J Hematol 1987; 24: 311- 326.
- Di Mario A, De Stefano V, Mele L, Musuvuci E, Leone G. Successful treatment with cyclosporine A of pure red cell aplasia occurring 11 years after thymectomy. Eur J Haematol 1998; 61: 221- 222.
- Truong MT, Sabloff BS, Gladish GW, Whitman GJ, Munden RF. Radiologic- Pathologic conferences of the University of Texas M. D. Anderson Cancer Center. Invasive Thymoma. AJR Am J Roentgenol 2003; 181: 1504.
- Baron RL, Lee JK, Sagel SS, Levitt RG. Computed tomography of the abnormal thymus. Radiology 1982; 142: 127- 134.
- Rosado de Christenson ML, Galobardes J, Moran CA. Thymoma: Radiologic- pathologic correlation. Radiographics 1992 ; 12 : 151- 68.
- Chu KC, Horm JW, Smart Cr. Estimating cancer mortality rates from SEER incidence and survival data. Public Health Rep 1990; 105: 36- 46.
- Inaoka T, Takahashi K, Mineta M, Yamada T, Shuke N, Okizaki A, Nagasawa K, Sugimori H, Aburano T. Thymic hyperplasia and thymus gland tumors: Differentiation with chemical shift MR imaging. Radiology 2007; 243: 869- 876.
- Rosai J, Sobin LH. Histological typing of tumours of the thymus. International histological classification of tumours, 2nd edition. New York: Springer, 1999.
- Masaoka A, Monden Y, Ankara K, Tanioka T. Follow- up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485- 2492.
- Kim DJ, Yang WI, Choi SS, Kim KD, Chung KY. Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors. A clinicopathologic study of 108 patients and literature review. Chest 2005; 127: 755- 761.
- Rosenow EC III, Hurley BT. Disorders of the thymus. A review. Arch Intern Med 1984; 144: 763- 770.
- Baron RL, Lee JK, Sagel SS, Peterson RR. Computed tomography of the normal thymus. Radiology 1982; 142: 121 125.
- Naidich DP, Müller NL, Zerhouni EA. Mediastinum. En: Naidich DP, Müller NL, Zerhouni EA. Computed Tomography and Magnetic Resonance of the thorax. Tercera edición. Filadelfia: Lippincott- Raven publishers; 1999: 37- 160.
- Inaoka T, Takahashi K, Mineta M, Yamada T, Shuke N, Okizaki A, Nagasawa K, Sugimori H, Aburano T. Thymic hyperplasia and thymus gland tumors: Differentiation with chemical shift MR imaging. Radiology 2007; 243: 869- 876.
- Higuchi T, Taki J, Kinuya S, Yamada M, Kawasuji M, Matsui O et al. Thymic lesions in patients with myastenia gravis: Characterization with Thallium 201 Scintigraphy. Radiology 2001; 221: 201-206.
- Kondo K. Optimal therapy for thymoma. J Med Invest 2008; 55: 17- 28.
- Johnson SB, Eng TY, Giaccone G, Thomas CR Jr. Thymoma: Update for the new millenium. The Oncologist 2001; 6: 239 246.
- Dessypris EM. The biology of pure aplasia. Semin Hematol 1991; 28: 275- 284.
- Suzuki S, Nogawa S, Tanaka K, Koto A, Fukuuchi Y, Kuwana M. Initial predictors of development of pure red cell aplasia in myasthenia gravis after thymectomy. Clin Neurol Neurosurg 2003; 106: 16- 18.
- Mizobuchi S, Yamashiro T, Nonami Y, Yamamoto A, Kume M, Nakaya H et al. Pure red cell aplasia and myasthenia gravis with thymoma: A case report and review of the literature. Jpn J Clin Oncol 1998; 28: 696- 701.
- Sonobe S, Miyamoto H, Izumi H, Nobukawa B, Futagawa T, Yamazaki A et al. Clinical usefulness of the SHO histological classification of thymoma. Ann Thorac Cardiovasc Surg 2005; 11: 367- 373.
Information
Journal history
Keywords
QR code
Funding
Directories and indexes
